Fluoroquinolone consumption and Escherichia coli resistance in Japan: an ecological study

BMC Public Health. 2019 Apr 23;19(1):426. doi: 10.1186/s12889-019-6804-3.

Abstract

Background: The frequency of antimicrobial resistance has steadily increased worldwide, induced by inappropriate use of antibiotics in a variety of settings. We analyzed the ecological correlation between fluoroquinolone consumption and levofloxacin resistance in Escherichia coli in Japan.

Methods: We collected information on cases of E. coli resistant to levofloxacin in 2015-2016 in all 47 prefectures from the Japan Nosocomial Infections Surveillance system. Information on fluoroquinolone consumption was obtained from pharmaceutical sales data. To address potential confounding, we also collected information on the number of physicians, nurses, and medical facilities per 100,000 individuals.

Results: We identified higher fluoroquinolone consumption and higher resistance in western prefectures, and lower consumption and resistance in eastern prefectures. Multivariate analysis identified a positive correlation between fluoroquinolone consumption and levofloxacin resistance in both 2015 and 2016.

Conclusions: Fluoroquinolone consumption and levofloxacin-resistant E. coli are potentially associated on a nationwide scale. The relationship between the two must be elucidated using additional studies with different epidemiological designs, so that any possible counter-measures, including alternative prescription, can be considered in the future.

Keywords: Antibiotic resistance; Antimicrobial stewardship; Drug prescription; Epidemiology; Escherichia coli; Quinolones.

MeSH terms

  • Anti-Bacterial Agents / supply & distribution*
  • Cross Infection / drug therapy
  • Cross Infection / epidemiology
  • Databases, Pharmaceutical / statistics & numerical data
  • Drug Resistance, Bacterial*
  • Escherichia coli / drug effects*
  • Escherichia coli Infections / drug therapy
  • Escherichia coli Infections / epidemiology*
  • Fluoroquinolones / supply & distribution*
  • Geography
  • Humans
  • Japan / epidemiology
  • Levofloxacin / pharmacology
  • Microbial Sensitivity Tests

Substances

  • Anti-Bacterial Agents
  • Fluoroquinolones
  • Levofloxacin